Drugs / Cerebralcare pills
Cerebralcare pills
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05578521 | Jun 2022 → Dec 2023 | cerebrovascular disorder | Beijing Tiantan Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cerebralcare pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05578521 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Cerebralcare pills, a traditional Chinese medicine with multiple pharmacological mechanisms, may be effective in treating cognitive dysfunction in CSVD.” PMID 40897453 ↗ Apr 2026 |
| Route | Oral | “Participants were randomised 1:1 to orally take 5 g of Cerebralcare pills or placebo twice a day for 6 months.” PMID 40897453 ↗ Apr 2026 |